Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
ORIC Pharmaceuticals announced inducement grants consisting of 80,000 stock options and 15,000 restricted stock units to a new non-executive employee who joined in March 2026. The grants are subject to vesting and were approved under Nasdaq listing rules as an employment inducement. ORIC continues its clinical stage development of oncology treatmen…
AIOS Tech Inc. announced that Nasdaq notified the company for failing to meet the minimum $1 bid price requirement over the last 30 consecutive trading days. Nasdaq granted a 180-day period for the company to regain compliance, with the possibility of an additional 180-day extension if other criteria are met. The company is evaluating options, incl…
Xilio Therapeutics announced the granting of non-qualified stock options to two new employees as inducement awards under its 2022 Inducement Stock Incentive Plan. The options are for 3,257 shares with an exercise price of $8.48 per share, matching the closing stock price on April 1, 2026. The vesting schedule spans over four years, contingent upon …
IN8bio, a clinical-stage biopharmaceutical company specializing in γδ T cell therapies for cancer and autoimmune diseases, announced an inducement grant of 11,800 stock options to two new employees outside its 2023 Equity Incentive Plan. The options vest over four years and were granted in accordance with Nasdaq listing requirements to incentivize …
First Hawaiian, Inc., Hawaii's oldest and largest bank holding company, will release its first quarter 2026 financial results on April 24, 2026, before the U.S. market opens. The company will host a conference call the same day to discuss results, accessible via phone and webcast. First Hawaiian operates banking services across Hawaii, Guam, and Sa…
Arhaus, Inc., a premium home furnishings brand, announced the opening of a 19,300-square-foot showroom in Ashburn, Virginia, marking its fifth location in the state. The showroom offers customers a curated collection of artisan-crafted furniture in a design-forward setting, complemented by complimentary design services and a relaunched Trade Progra…
Spyre Therapeutics has granted stock options totaling 70,200 shares to five newly hired non-executive employees as inducement awards. The options have a 10-year term, an exercise price of $48.90 per share, and will vest over four years. This move aims to attract talent and support the company's ongoing clinical development of long-acting antibody t…
Syndax Pharmaceuticals granted inducement stock options for 228,500 shares to eight new employees as part of its 2023 Inducement Plan. These options vest over four years and are aimed at attracting and retaining talent to support its cancer therapy pipeline and ongoing clinical trials.
Intellia Therapeutics announced inducement grants of 67,150 restricted stock units to 13 new employees as a material inducement to employment under its 2024 Inducement Plan. The RSUs vest over three years and were granted outside the company's stockholder-approved equity plans under Nasdaq Listing Rule 5635(c)(4).
AEON Biopharma announced it received an additional notice from NYSE American indicating non-compliance with an additional listing standard due to stockholders' equity deficit and continued losses. Although this does not immediately impact its listing or previously established compliance plan, failure to regain compliance by August 3, 2026, could le…
AEON Biopharma announced inducement grants totaling over 990,000 restricted stock units to newly appointed CFO John Bencich. These equity awards are designed to incentivize his employment and align his interests with the company, with vesting tied to his service and AEON's regaining compliance with NYSE American listing standards. The company is fo…
RCM Technologies, Inc. announced robust financial results for the fourth quarter and fiscal year ending January 3, 2026, demonstrating solid growth in revenue, gross profit, and net income compared to the prior year and quarter. The company experienced notable increases in both GAAP and non-GAAP metrics, including a 12.4% revenue growth quarter-ove…
WW International, Inc. announced the departure of CEO Tara Comonte and has established an Office of the CEO led by senior executives during the search for a permanent successor. The Board formed a Transition Committee to oversee leadership changes and governance matters. Additionally, Debra Cotter was appointed chief legal officer and secretary. Th…
Impact BioMedical Inc. disclosed a 'going concern' qualification in its 2025 10-K audit report highlighting financial uncertainties. Despite this, the company continues with its planned strategic merger with Dr. Ashley's Ltd., anticipated by July 1, 2026.
Denali Therapeutics announced Takeda's decision to terminate their collaboration on DNL593, a progranulin replacement therapy for frontotemporal dementia linked to GRN mutations. Denali will continue clinical development independently and plans to report Phase 1/2 study results by the end of 2026. The investigational therapy uses Denali's Transport…
Ponce Bank, a minority-led community bank subsidiary of Ponce Financial Group, Inc., was ranked #40 among the Top 50 Best-Performing U.S. Community Banks in the $3 billion to $10 billion asset category by S&P Global Market Intelligence, highlighting its strong financial performance and commitment to community development.
HII's Ingalls Shipbuilding hosted former U.S. Senator Sam Nunn and family to observe the construction progress of the USS Sam Nunn (DDG 133), a Flight III Arleigh Burke-class destroyer named in his honor. The visit highlights ongoing advancements in this key naval shipbuilding project, which incorporates modern defense technologies to enhance U.S. …
First Bank, a New Jersey state-chartered bank with operations from New York to Florida, announced its first quarter 2026 earnings release on April 27, 2026, followed by a conference call on April 28, 2026. Executives will discuss the bank's financial and operating performance, providing investors with insights into recent results and outlook.
Navient will release its first quarter 2026 financial results on April 29, hosting an audio webcast and providing presentation materials to investors. The results will also be filed with the SEC and accessible via the company's investor website.
HII's Newport News Shipbuilding division has successfully completed post-shakedown availability work on the USS New Jersey (SSN 796), a Virginia-class fast attack submarine, and redelivered it to the U.S. Navy. The maintenance period included combat systems and electronics upgrades, ensuring enhanced operational readiness and reinforcing the nation…
Rhythm Pharmaceuticals announced a change to its board of directors with the addition of Kim Popovits, an experienced biotech leader, and the departure of longtime director Ed Mathers. The company highlighted Popovits' expertise to support its ongoing growth and commercialization efforts, particularly for its rare disease treatments.
Bicara Therapeutics, a clinical-stage biopharmaceutical company focused on bifunctional therapies for solid tumors, announced an inducement grant of stock options to a new employee. The grant, approved under Nasdaq listing rules, includes options to purchase 44,175 shares at the closing price of $20.50 per share, vesting over time with continued em…
Taysha Gene Therapies announced that it granted restricted stock units and stock options totaling 392,400 shares to four new employees as inducements for their employment. These equity awards are subject to vesting schedules and comply with Nasdaq Listing Rule 5635(c)(4). The company focuses on developing AAV-based gene therapies for severe monogen…
MBX Biosciences, a clinical-stage biopharmaceutical company focused on precision peptide therapies for endocrine and metabolic disorders, announced an inducement grant of non-qualified stock options totaling 130,000 shares to Karen Basbaum upon her appointment as Chief Business Officer. The options have an exercise price of $32.29 per share, a 10-y…
Lotus Technology Inc. has showcased two premier Emira models, including the new Racing Line Edition, at the 2026 New York International Auto Show. The Racing Line Edition emphasizes the brand's heritage with track-inspired design and performance enhancements, reinforcing Lotus's commitment to craftsmanship and luxury driving experiences.
